Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	111.27	159.52	334.43	326.4	95.01
Short-Term Investments	112.36	184.42	7.44	7.53	0
Cash & Cash Equivalents	223.63	343.94	341.87	333.92	95.01
Cash Growth	-34.98%	0.61%	2.38%	251.48%	769.29%
Receivables	4.5	4.32	0.65	4.15	1.98
Other Current Assets	15.56	5.72	8.89	8.48	1.59
Total Current Assets	243.69	353.98	351.41	346.55	98.57
Property, Plant & Equipment	7.54	9.6	13.1	8.62	3.42
Other Long-Term Assets	2.67	0.5	4.21	1.91	0.7
Total Long-Term Assets	10.21	10.1	17.3	10.53	4.12
Total Assets	253.9	364.08	368.72	357.09	102.7
Accounts Payable	2.4	0.46	2.3	2.25	2.13
Deferred Revenue	11.95	55.78	51.53	58.01	8.14
Current Debt	2.4	2.17	1.72	0.7	0.63
Other Current Liabilities	22.33	20.2	-20.47	-49.94	-6.65
Total Current Liabilities	39.08	78.62	35.09	11.01	4.25
Long-Term Debt	1.01	3.26	5.59	3.31	0.44
Other Long-Term Liabilities	1.73	2.68	39.61	55.93	8.14
Total Long-Term Liabilities	2.74	5.94	45.21	59.24	8.58
Total Liabilities	41.82	84.56	80.29	70.26	12.83
Total Debt	3.41	5.43	7.31	4.01	1.06
Debt Growth	-37.18%	-25.78%	82.60%	276.41%	-
Retained Earnings	-333.11	-239.31	-210.27	-103.36	-49.94
Comprehensive Income	0.03	-0.43	0	0	0
Shareholders' Equity	212.08	279.52	288.42	286.83	-46.13
Net Cash / Debt	220.22	338.51	334.55	329.92	93.94
Net Cash / Debt Growth	-34.95%	1.18%	1.41%	251.20%	759.56%
Net Cash Per Share	5.23	8.07	8.85	16.46	61.46
Working Capital	204.61	275.36	316.33	335.54	94.33
Book Value Per Share	5.04	6.67	7.63	14.31	-30.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).